Akari Therapeutics's total assets for Q2 2024 were $5.08M, an increase of 83.12% from the previous quarter. AKTX total liabilities were $60.97M for the fiscal quarter, a 4.19% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.